ArticleFrontiers in medicine2021

High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study.

Qiaoling Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.